Sort
261,768 grants matching “gene therapy”
Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry
$847,772Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
AAV-mediated gene therapy for GM2-gangliodoses
$847,727Miguel S Esteves · Univ Of Massachusetts Med Sch Worcester · U01 · FY2012 · NS
Limiting HIV establishment and maintenace by preserving intestinal immunity
$847,715Siddappa N Byrareddy · University Of Nebraska Medical Center · R01 · FY2017 · AI
Sustained HIV Remission via Sequence-Specific Epigenetic Silencing of Latent Proviruses
$847,711Fabio Romerio · University Of Maryland Baltimore · R01 · FY2020 · AI
Preclinical Development of a Novel and Powerful Immunotherapeutic
$847,617Susan Dana Jones · Immurx Llc · R44 · FY2012 · AI
Vaccines and Therapeutics for Anthrax
$847,612Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Angiogenesis and Tumor Growth
$847,609Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Therapeutic Dendritic Cell Vaccine for HIV
$847,500Nathaniel R. Landau · New York University School Of Medicine · DP1 · FY2020 · DA
Therapeutic Dendritic Cell Vaccine for HIV
$847,500Nathaniel R. Landau · New York University School Of Medicine · DP1 · FY2023 · DA
C-TRIP: Targeted Gene Therapy for the Treatment of Heart Failure (P20)
$847,500Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · P20 · FY2011 · HL
Therapeutic Dendritic Cell Vaccine for HIV
$847,500Nathaniel R. Landau · New York University School Of Medicine · DP1 · FY2021 · DA
Therapeutic Dendritic Cell Vaccine for HIV
$847,500Nathaniel R. Landau · New York University School Of Medicine · DP1 · FY2019 · DA
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$847,498Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK
First-in-human study of a potent anti-HBsAg neutralizing antibody
$847,498Marina Caskey · Rockefeller University · U01 · FY2024 · AI
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$847,498Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$847,498Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DK
Translational Studies in Heart Failure Gene Therapy
$847,498Charles R Bridges · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · HL
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$847,498Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK
Translational Studies in Heart Failure Gene Therapy
$847,498Charles R Bridges · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · HL
Translational Studies in Heart Failure Gene Therapy
$847,498Charles R Bridges · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL
Investigating genomic factors and microbiome features that impact CDI transmission and prognosis
$847,495Ali M Bashir · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · AI
Investigating genomic factors and microbiome features that impact CDI transmission and prognosis
$847,495Harm Van Bakel · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · AI
Investigating genomic factors and microbiome features that impact CDI transmission and prognosis
$847,495Harm Van Bakel · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AI
Investigating genomic factors and microbiome features that impact CDI transmission and prognosis
$847,495Harm Van Bakel · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AI
Initiation Of DNA Replication In Mammalian Chromosomes
$847,492Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD